INMB

INmune Bio Inc.

12.64 USD
-0.28 (-2.17%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

INmune Bio Inc. stock is up 4.64% since 30 days ago. The next earnings date is Mar 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 5 February’s closed higher than January.

About INmune Bio Inc.

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation.